Cynata
An Australian clinical-stage stem cell and regenerative medicine company focused on the development of therapies based on a proprietary therapeutic stem cell platform technology.
Launch date
Employees
Market cap
$22.2m
Enterprise valuation
$18m (Public information from Sep 2024)
Share price
AUD0.22 CYP.AX
Melbourne Victoria (HQ)
Authorizing premium user...